Pilot Study of COR-1 in Heart Failure

NCT01391507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy, Dilated

Interventions

DRUG: 0.9 % sodium chloride
DRUG: COR-1
DRUG: Standard therapy for heart failure

Sponsor

Corimmun GmbH